HomeTechEquipmentEli Lilly (LLY) Hits High After Diabetes Drug Approval
00:00
00:00
06:47
Eli Lilly (LLY) Hits High After Diabetes Drug Approval

Eli Lilly (LLY) Hits High After Diabetes Drug Approval

Eli Lilly (LLY) is higher after Chinese regulators approve diabetes drug in China. Diane King Hall discusses this as Eli Lilly’s Phase 3 study of Crohn’s disease treatment achieves “meaningful improvements.” Eli Lilly hit a new all-time high today. Tune in to find out more about the stock market today.

Next Gen Investing

21 May 2024

SHARE

ON AIR
12:00 pm
Gamma On
replay
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:00 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
ON AIR
12:00 pm
Gamma On
REPLAY
1:00 pm
Morning Movers
2:00 pm
Morning Trade Live
4:00 pm
Trading 360
5:00 pm
Fast Market
6:00 pm
Next Gen Investing
7:00 pm
The Watch List
8:00 pm
Market On Close
9:30 pm
Market Overtime
REPLAY
10:00 pm
Trading 360
REPLAY
11:00 pm
Fast Market
REPLAY
12:00 am
Next Gen Investing
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
3:00 am
Gamma On
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Inside the Mind of a Trader
REPLAY
education
5:00 am
Inside the Mind of a Trader
REPLAY
education
5:30 am
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor